• Shalini Dhir and Achal Dhir.
• Department of Anesthesia and Perioperative Medicine, Western University, London, Ontario, Canada. Electronic address: shalini.dhir@sjhc.london.on.ca.
• J. Cardiothorac. Vasc. Anesth. 2020 Jul 1; 34 (7): 1914-1924.

AbstractBiomarkers aided perioperative cardiac assessment is a relatively new concept. Cardiac biomarkers with historical significance (aspartate transaminase, dehydrogenase, creatinine kinase and myoglobin) have paved the way for traditional biomarkers (cardiac troponin, C-reactive protein, lipoprotein). Contemporary biomarkers like natriuretic peptides (BNP and ProBNP) are validated risk markers in both acute and chronic cardiac diseases and are showing remarkable promise in predicting serious cardiovascular complications after non-cardiac surgery. This review is intended to provide a critical overview of traditional and contemporary biomarkers for perioperative cardiovascular assessment and management. This review also discusses the potential utility of newer biomarkers like galectin-3, sST-2, GDF-15, TNF-alpha, MiRNAs and many others that can predict inflammation, cardiac remodeling, injury and endogenous stress and need further investigations to establish their clinical utility. Though promising, biomarker led perioperative care is still in infancy and it has not been determined that it can improve clinical outcomes.Copyright © 2019 Elsevier Inc. All rights reserved.

17 keywords...

hide…